0.011116
0.000000
0.000000
0.000000
0.011116
0.000000
0.000000
0.000000
0.011116
0.00000
0.00000
0.00000
RESIDUES 18 AND 44 ARE CIS-PROLINES.
Chen, P.
Rose, J.
Wang, B.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
24
90.00
90.00
90.00
89.960
89.960
89.960
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
267
1990
1994
1730730
Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors.
1992
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
258
9357
Crystallization of Two Cubic Forms of Soybean Trypsin Inhibitor E-I, a Member of the Bowman-Birk Inhibitor Family
1983
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7213.337
BOWMAN-BIRK INHIBITOR (PI-II)
1
man
polymer
no
no
DEYSKPCCDLCMCTRSMPPQCSCEDRINSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKSR
DEYSKPCCDLCMCTRSMPPQCSCEDRINSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKSR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
soybean
Glycine
sample
3847
Glycine max
4.20
70.73
repository
Initial release
Version format compliance
Version format compliance
1
0
1992-04-15
1
1
2008-03-24
1
2
2011-07-13
Y
1991-03-26
REL
n
1
1
A
n
2
2
A
TYR
3
n
3
TYR
3
A
SER
4
n
4
SER
4
A
LYS
5
n
5
LYS
5
A
PRO
6
n
6
PRO
6
A
CYS
7
n
7
CYS
7
A
CYS
8
n
8
CYS
8
A
ASP
9
n
9
ASP
9
A
LEU
10
n
10
LEU
10
A
CYS
11
n
11
CYS
11
A
MET
12
n
12
MET
12
A
CYS
13
n
13
CYS
13
A
THR
14
n
14
THR
14
A
ARG
15
n
15
ARG
15
A
SER
16
n
16
SER
16
A
MET
17
n
17
MET
17
A
PRO
18
n
18
PRO
18
A
PRO
19
n
19
PRO
19
A
GLN
20
n
20
GLN
20
A
CYS
21
n
21
CYS
21
A
SER
22
n
22
SER
22
A
CYS
23
n
23
CYS
23
A
GLU
24
n
24
GLU
24
A
ASP
25
n
25
ASP
25
A
ARG
26
n
26
ARG
26
A
ILE
27
n
27
ILE
27
A
ASN
28
n
28
ASN
28
A
SER
29
n
29
SER
29
A
CYS
30
n
30
CYS
30
A
HIS
31
n
31
HIS
31
A
SER
32
n
32
SER
32
A
ASP
33
n
33
ASP
33
A
CYS
34
n
34
CYS
34
A
LYS
35
n
35
LYS
35
A
SER
36
n
36
SER
36
A
CYS
37
n
37
CYS
37
A
MET
38
n
38
MET
38
A
CYS
39
n
39
CYS
39
A
THR
40
n
40
THR
40
A
ARG
41
n
41
ARG
41
A
SER
42
n
42
SER
42
A
GLN
43
n
43
GLN
43
A
PRO
44
n
44
PRO
44
A
GLY
45
n
45
GLY
45
A
GLN
46
n
46
GLN
46
A
CYS
47
n
47
CYS
47
A
ARG
48
n
48
ARG
48
A
CYS
49
n
49
CYS
49
A
LEU
50
n
50
LEU
50
A
ASP
51
n
51
ASP
51
A
THR
52
n
52
THR
52
A
ASN
53
n
53
ASN
53
A
ASP
54
n
54
ASP
54
A
PHE
55
n
55
PHE
55
A
CYS
56
n
56
CYS
56
A
TYR
57
n
57
TYR
57
A
LYS
58
n
58
LYS
58
A
PRO
59
n
59
PRO
59
A
CYS
60
n
60
CYS
60
A
LYS
61
n
61
LYS
61
A
SER
62
n
62
SER
62
A
ARG
63
n
63
ARG
63
A
author_defined_assembly
6
hexameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
19_555
-x+3/4,-z+3/4,-y+3/4
crystal symmetry operation
67.4700000000
67.4700000000
67.4700000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
-1.0000000000
0.0000000000
0.0000000000
10_655
-y+1,z+1/2,-x+1/2
crystal symmetry operation
89.9600000000
44.9800000000
44.9800000000
0.0000000000
0.0000000000
-1.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
7_564
-z+1/2,-x+1,y-1/2
crystal symmetry operation
44.9800000000
89.9600000000
-44.9800000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
-1.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
22_564
z+1/4,-y+5/4,x-1/4
crystal symmetry operation
22.4900000000
112.4500000000
-22.4900000000
0.0000000000
1.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
13_455
y-1/4,x+1/4,-z+1/4
crystal symmetry operation
-22.4900000000
22.4900000000
22.4900000000
1
A
OG
SER
62
A
OG
SER
62
1
Y
1
A
CG
ARG
63
A
CG
ARG
63
1
Y
1
A
CD
ARG
63
A
CD
ARG
63
1
Y
1
A
NE
ARG
63
A
NE
ARG
63
1
Y
1
A
CZ
ARG
63
A
CZ
ARG
63
1
Y
1
A
NH1
ARG
63
A
NH1
ARG
63
1
Y
1
A
NH2
ARG
63
A
NH2
ARG
63
1
Y
1
A
ASP
1
A
ASP
1
1
Y
1
A
GLU
2
A
GLU
2
1
Y
1
9.10
1.40
123.60
132.70
A
A
A
CD
NE
CZ
ARG
ARG
ARG
15
15
15
N
1
8.78
1.10
114.20
122.98
A
A
A
CA
CB
SG
CYS
CYS
CYS
21
21
21
N
1
-15.31
1.80
110.60
95.29
A
A
A
N
CA
CB
CYS
CYS
CYS
23
23
23
N
1
19.94
2.70
111.00
130.94
A
A
A
N
CA
C
CYS
CYS
CYS
23
23
23
N
1
-13.95
1.60
122.70
108.75
A
A
A
O
C
N
CYS
CYS
GLU
23
23
24
Y
1
17.51
2.50
121.70
139.21
A
A
A
C
N
CA
CYS
GLU
GLU
23
24
24
Y
1
-12.86
2.00
110.40
97.54
A
A
A
CB
CA
C
GLU
GLU
GLU
24
24
24
N
1
18.03
2.50
121.70
139.73
A
A
A
C
N
CA
GLU
ASP
ASP
24
25
25
Y
1
11.80
0.90
118.30
130.10
A
A
A
CB
CG
OD1
ASP
ASP
ASP
25
25
25
N
1
-9.96
0.90
118.30
108.34
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
1
17.25
2.70
111.00
128.25
A
A
A
N
CA
C
ASP
ASP
ASP
25
25
25
N
1
5.76
0.50
120.30
126.06
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
1
-3.70
0.50
120.30
116.60
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
26
26
26
N
1
10.61
1.40
123.60
134.21
A
A
A
CD
NE
CZ
ARG
ARG
ARG
41
41
41
N
1
4.81
0.50
120.30
125.11
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
41
41
41
N
1
A
A
N
O
GLN
GLN
43
43
1.66
1_555
19_555
1
A
A
N
O
ARG
CYS
15
37
2.08
1_555
10_655
1
A
ARG
15
-79.23
33.62
1
A
CYS
23
-131.29
-129.51
1
A
ASN
28
77.09
-34.88
1
A
SER
62
-179.14
-64.08
0.236
2.5
1
2.5
0
461
0
0
461
0.012
2.8
refinement
GPRLSA
BOWMAN-BIRK PROTEINASE INHIBITOR PI-II
REACTIVE SITES OF AN ANTICARCINOGENIC BOWMAN-BIRK PROTEINASE INHIBITOR ARE SIMILAR TO OTHER TRYPSIN INHIBITORS
1
N
N
disulf
1.944
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
60
A
SG
CYS
60
1_555
disulf
1.980
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
2.076
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
56
A
SG
CYS
56
1_555
disulf
2.025
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
1.920
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
37
A
SG
CYS
37
1_555
disulf
1.992
A
CYS
34
A
SG
CYS
34
1_555
A
CYS
49
A
SG
CYS
49
1_555
disulf
2.008
A
CYS
39
A
SG
CYS
39
1_555
A
CYS
47
A
SG
CYS
47
1_555
SERINE PROTEINASE INHIBITOR
SERINE PROTEINASE INHIBITOR
A
MET
17
A
MET
17
1
A
PRO
18
A
PRO
18
-4.05
A
GLN
43
A
GLN
43
1
A
PRO
44
A
PRO
44
0.11
IBBD2_SOYBN
UNP
1
1
P01064
MCILSFLKSDQSSSYDDDEYSKPCCDLCMCTRSMPPQCSCEDIRLNSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKS
RDD
18
81
1PI2
1
63
P01064
A
1
1
63
1
ILE
DELETION
1PI2
A
P01064
UNP
43
1
LEU
CONFLICT
ILE
27
1PI2
A
P01064
UNP
45
27
2
2
anti-parallel
anti-parallel
A
CYS
11
A
CYS
11
A
ARG
15
A
ARG
15
A
GLN
20
A
GLN
20
A
ILE
27
A
ILE
27
A
SER
36
A
SER
36
A
THR
40
A
THR
40
A
GLN
46
A
GLN
46
A
ASN
53
A
ASN
53
213
P 41 3 2